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Abstract
Tetrapyrrole molecules are distributed in virtually all living organisms on Earth. In mammals,
tetrapyrrole end products are closely linked to oxygen metabolism. Since increasingly complex
trophic functional systems for using oxygen are considered in the post-traumatic inflammatory
response, it can be suggested that tetrapyrrole molecules and, particularly their derived pigments,
play a key role in modulating inflammation.
In this way, the diverse colorfulness that the inflammatory response triggers during its evolution
would reflect the major pathophysiological importance of these pigments in each one of its phases.
Therefore, the need of exploiting this color resource could be considered for both the diagnosis
and treatment of the inflammation.
Background
The inflammatory response related to surgery (elective or
anesthetized injury) and to trauma (accidental or unanes-
thetized injury) could be considered a surgical inflamma-
tion [1]. The surgical inflammation, as an inflammatory
process, could be viewed as composed of a series of over-
lapping successive phases [2]. That is why it is common
that each researcher chooses for his study a specific aspect
of this complex response. At the same time, the interrela-
tion of the knowledge that is successively obtained allows
for better understanding the pathophysiological mecha-
nisms of the surgical inflammation. It also allows for sug-
gesting new possible meanings of this inflammatory
response.
Color is a quality of the surgical inflammation that has
always been observed. The color in inflammation is one
of the components by which the classical description of
inflammation accounts for the visual changes observed.
Based on visual observation, the ancients characterized
inflammation by four cardinal signs, namely redness,
swelling, heat and pain [3].
It could be considered that the color of the injured tissue
is changeable because both the traumatic injury (contu-
sion and/or wound) and the inflammatory response
related to this aggression are evolutive. The post-traumatic
acute inflammatory response has especially been
described as a succession of three functional phases with
increasingly complex trophic functional systems for using
oxygen [2,4]. It is considered that also the state of wound
oxygenation is a key determinant of healing outcomes [5].
And, interestingly enough, it could be imagined that an
array of colors is displayed through this evolution. There-
fore, it could be considered that tetrapyrrole molecules,
such as heme, in addition to contributing a large variety of
colors to the tissues, are employed through the evolutive
process of acute inflammation. The great variability of
tetrapyrrole end-products, diversified both in plant and
animal life during the evolution of eukaryotic cells could
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changes imposed by the development in different envi-
ronments, from an unbreathable atmosphere to an envi-
ronment fully enriched by oxygen [2].
Tissue injury and inflammation
- Tissue injury
In mechanical trauma, it is considered that the inflamma-
tory response is induced by tissue injury [1,2]. However,
its special initial superimposition suggests that a continu-
ous pathophysiological mechanism is established.
Tissue injury due to mechanical energy can produce a con-
tusion (bruise), that is, damage without tissue breakage or
damage with tissue breakage. In this last case, if the tissue
is soft, the lesion is called a wound and if the tissue is
hard, the lesion is called a fracture [6].
The contusion, based on its severity, could be classified in
three degrees: first degree, characterized by the temporary
loss of function. Although it could be associated with
edema, the alterations are reversible, and therefore, full
recovery is possible. Second degree would occur with
ecchymosis, namely with tissue infiltration by red blood
cells. The evolution would be ambivalent since cellular
and tissue alterations can be reversed or worsened, caus-
ing cell death. Thus, the oxygen plays a key role in the evo-
lution of the second degree contusions since extreme near
anoxic environment is not compatible with tissue repair
[5]. And lastly, the third degree is an irreversible lesion
since the injury causes cell death by necrosis and the tissue
suffers from infarction [6] (Figure 1).
Cellular and tissue lesion is irreversible in the wound and
fracture since necrosis is produced. [6]. Particularly, the
wound enters the tissue suffering from a first, second or
third-degree overlapped contusion areas, as the figure 2
shows. In the third-degree contusion area, anoxia avoids
the wound repair. The evolution of the second-degree
bruised area, whether reversible or irreversible, will deter-
mine the evolution of the wound since it can increase the
necrosis area. Hypoxia in this area could be mild or mod-
est. At last, in the first-degree contusion area, that is the
most peripheral area around the wound, the inexistence
of hypoxia avoids the complications development and,
therefore it does not affect the tissue viability.(Figure 2).
Until recently, necrosis has often been viewed as an acci-
dental and uncontrolled cell death process. Nevertheless,
growing evidence supports the idea that necrotic cell
death may also be programmed [7]. Cellular signaling
events have been identified to initiate necrotic destruction
that could be blocked by inhibiting discrete cellular proc-
esses [8]. The most relevant mechanisms culminating in
cell necrosis correspond to mitochondrial dysfunction
and ATP depletion; loss of intracellular ion homeostasis
with osmotic swelling and oxidative stress; activation of
degrative hydrolases, including proteases, phosphory-
lases, and endonucleases; and degradation of cytoskeletal
proteins with disruption of cytoskeletal integrity [9]. Sur-
prisingly enough, this list of mechanisms also corre-
sponds to those that occur in the acute inflammatory
Degrees of severity in the contusionsFigur  1
Degrees of severity in the contusions. Injury without 
breakage produced by blunt etiological agents and are made 
up of concentric areas of different degrees of severity. From 
the cellular point of view, the first-degree contusion is a 
reversible injury. The alteration consists in small plasma bleb 
formation. In the second-degree contusion, a fusion of the 
blebs is produced and the plasma membrane permeability 
increases. In the third-degree contusion, cell death is pro-
duced by necrosis. At the same time, contusions can be 
superficial or deep. From the tissue point of view, edema is 
produced in the first-degree contusion; ecchymosis would be 
associated with edema in the second-degree contusion; an 
infarction would be produced in the third-degree contusion. 
Ecchymosis means that the red blood cells are the first blood 
cells to infiltrate the interstitial space in post-traumatic 
inflammation. Ecchymosis, also called a contusion or a bruise, 
due to its blue color, from the Latin word cardinus (bluish) 
explains its purple color.Page 2 of 15
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to injury, cells can develop a mechanism that would play
a defensive role (inflammation) and that could favor
reversing the alterations until their inadequate expression
would make them harmful (necrotic). Hence, at a specific
moment in time, the pathophysiological mechanisms
(cellular response to injury) become pathogenic mecha-
nisms (producers of cell death) [4].
- Tissue Inflammation
We have proposed that the acute inflammatory response
to injury by mechanical energy, regardless of whether it is
local or systemic, is based on the successive pathologic
functional predominance of the nervous, immune and
endocrine systems. This hypothesis implies that the final
and prevalent pathologic functions of these systems may
represent the consecutive phases of the response to stress
developed by the body, all of which may have a trophic
meaning for the injured tissue [4,10].
Perhaps the leading role in this response is played by the
relation between the blood and the interstitial space. This
assumption is based on the fact that the different blood
components escape the intravascular space one by one in
order to occupy the interstitial space, where they play the
main role in the successive phases of the inflammatory
response. Therefore, the endothelium plays a bidirec-
tional mediating role between blood flow and the intersti-
tial space, which is where inflammation mainly takes
place [2,4].
Since the phases of the inflammatory response go from
ischemia to the development of an oxidative metabolism,
the successive pathophysiological mechanisms that
develop in the interstitium of tissues when they undergo
inflammation are considered increasingly complex
trophic functional systems for using oxygen [2,4,10].
- Phases of the Inflammatory Response
It could be considered that the acute post-traumatic
inflammatory response is made up of three overlapping
phases, whether local or systemic (Figure 3).
The first or immediate phase has been referred to as the
nervous phase, because the sensory (pain and analgesia)
and motor alterations (contraction and relaxation)
respond to the injury [2,4]. This early pathological activ-
ity, in essence, could reflect the predisposition of the
body's nociceptor nervous pathways to first suffer depo-
Schematic representation of a woundFigure 2
Schematic representation of a wound. Injury without 
breakage in the soft tissue can be superficial or deep. The 
contusive wounds induce a first, second and third-degree 
contusion in the tissues, as the figure shows. The evolution of 
the second-degree bruised area, whether reversible or irre-
versible, will determine the evolution of the wound since it 
can increase the necrosis area. The superficial injury with 
breakage has external hemorrhaging and the deep injury 
without breakage has contusions of internal tissue or intrapa-
renchymatous hemorrhaging. a: first-degree contusion; b: 
second-degree contusion; c: third-degree contusion
Phases of the post-traumatic inflammatory responseFigure 3
Phases of the post-traumatic inflammatory response. 
The post-traumatic inflammatory response is considered to 
be made up of three overlapping phases with increasingly 
complex trophic functional systems for using oxygen. During 
the first or nervous phase, oxidative and nitrosative stress 
are produced. In the second or immune phase, enzymatic 
stress is produced and in the third or endocrine phase, oxi-
dative phosphorylation is reached and therefore, energetic 
stress is produced. N: Nervous phase with oxidative stress 
and edema which progressively subsides(blue). I: Immune 
phase with enzymatic stress and its subsequent neutraliza-
tion(yellow). E: Endocrine phase with its initial tissue de-
structuring and subsequent tissue repair through regenera-
tion and/or fibroplasia.(red).Page 3 of 15
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production. Furthermore, this nervous response coexists
almost completely with the tissue injury evolution and,
therefore, conditions it.
The nervous or immediate functional system presents
ischemia-revascularization and edema, which favor nutri-
tion by diffusion through the injured tissue. In reality, the
tissues suffer ischemia-reoxygenation, that is, they begin
using oxygen after a more or less long period of ischemia.
It is likely that the magnitude of wound hypoxia is not
uniformly distributed throughout the affected tissue,
especially in large wounds [5]. This trophic mechanism
has a low energy requirement that does not require oxy-
gen (ischemia) or in which the oxygen is not correctly
used, with the subsequent excessive production of reactive
oxygen and nitrogen species (ROS/RNS) (reperfusion). In
this phase, while the progression of the interstitial edema
increases in the space between the epithelial cells and the
capillaries, the lymphatic circulation is simultaneously
activated (circulatory switch). Thus, the injured tissues
adopt an ischemic phenotype (hypoxia) [4] (Figure 3).
In the following immune or intermediate phase of the
inflammatory response, the tissues and organs which have
suffered ischemia-reperfusion, are infiltrated by inflam-
matory cells and, sometimes, by bacteria. Interstitial
inflammation is favored by the concurrent activation of
hemostasis and complement cascades. In the tissues and
organs which suffer oxidative stress, symbiosis of the
inflammatory cells and bacteria for extracellular digestion
by enzyme release (fermentation) and by intracellular
digestion (phagocytosis) could be associated with a hypo-
thetical trophic capacity. Improper use of oxygen persists
in this immune phase and is also associated with enzy-
matic stress. Furthermore, lymphatic circulation plays a
major role and macrophages and dendritic cells migrate to
lymph nodes where they activate lymphocytes [2,4,11]
(Figure 3).
It is considered that angiogenesis characterizes the last or
endocrine phase of the inflammatory response, so nutri-
tion mediated by the blood capillaries is established
[2,4,5]. However, the angiogenic process becomes active
early and excessive proliferation of endothelial cells takes
place which, in turn, develops a great density of endothe-
lial sprouts. Through this initial and excessive prolifera-
tion, the endothelial cells could successively perform
antioxidant and anti-enzymatic functions. These func-
tions would favor the evolution of the inflammatory
response towards tissue repair through specialized capil-
lary development. If so, it would be in this last phase of
the inflammatory response when the process of angiogen-
esis would be responsible for tissue nutrition through cap-
illaries. Oxygen got its name from "Principe Oxygen"
which means the acidifying principle."Oxy" is from Greek
and means sharp or acid; "gen" is also from Greek and
means the origin of. Taken together, oxygen means "the
origin of acid" [5]. Oxygen and oxidative metabolism are
an excellent combination through which cells can obtain
an abundant energy supply (energetic stress) for tissue
repair by epithelial regeneration or wound healing
[2,4,5,10,11] (Figure 3).
The color of the inflammatory phases
The colors of inflammation can be represented in three
groups:
- Cold colors
The tissue color that is initially associated with mechani-
cal injury is white. When mechanical energy acts on the
tissue, especially if this occurs through a blunt etiological
agent, an abrupt crushing is produced that takes the blood
out of the tissue. The bloodless tissue is white, a color that
brings together the entire light spectrum, but if it contin-
ues to be crushed, it becomes ominous since it can signal
sphacelation. Thus, in a third-degree contusion, the tissue
suffers a crush injury with vasospasm, endothelial damage
and thrombosis [12] (Figure 1).
Decreased transcutaneous oxygen tension, reduced arte-
rial hemoglobin saturation and increased transcutaneous
carbon dioxide tension revealed a reduction in blood flow
and poor tissue perfusion as the earliest warning signs of
shock and death [13]. Then, a shift to anaerobic metabo-
lism is provided through the metabolic adaptation to
hypoxia. Again the paleness, in this case generalized,
implies a poor prognosis.
Blood loss remains a leading cause of traumatic death
[14]. Control of bleeding and correction of intravascular
volume are the hallmarks of conventional resuscitation
after massive blood loss [14]. After cardiopulmonary
resuscitation of trauma patients with cardiac arrest, the
survival rates are only 0% to 5% [15,16]. Cardiac resusci-
tation (chest compression without ventilation) by
bystanders is the preferable approach for resuscitation
[17]. In blunt and/or penetrating trauma patients efforts
should be withheld in case there is evidence of a signifi-
cant time lapse since pulselessness, including lividity, rigor
mortis and decomposition [18].
Early care of the severely injured patient and intervention
for hypothermia, coagulopathy and acidosis, components
of the trauma triad of death, would improve shock resus-
citation [19-21]. Since cardiac arrest is an evolutive injury,
it has been suggested that the optimal treatment is phase-
specific and includes: the electrical phase (0–4 minutes),
the circulatory phase (4–10 minutes) and the metabolic
phase (beyond 10 minutes after cardiac arrest) [22]. InPage 4 of 15
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is the most effective measure [23].
Inflammatory pain is caused by tissue damage [24] and its
pathogeny also seems to be phase-specific. Thus, after the
initial electrical phase, with upregulation of ionic channel
expression in the nociceptive circuits that causes the spon-
taneous neural firing [24,25], the following would be an
immune phase, with cytokines, chemokines and prostag-
landins derived from glial and immune cells, acting as
pain mediators and modulators [26,27]. Lastly, in an
endocrine phase, neurotrophic factors, including nerve
growth factor (NGF), brain-derived neurotrophic factor
(BDNF) and neurotrophins 3 and 4, would be associated
with structural neural remodeling [28]. If so, the velocity
in which the phases of inflammation are expressed in the
neural tissue would allow it to play a modulating role in
the post-mechanical injury inflammatory response in the
rest of the tissues and organs of the body.
An immediate component of the stress response to pain is
the efferent nervous response mediated by the somatic
motor and autonomic nervous systems [29]. The somatic
motor response usually consists in the withdrawal of the
affected part of the body from the source of irritation.
Withdrawal reflexes are the simplest centrally organized
responses to painful stimuli [30]. Furthermore, the fight-
or-flight response is the behavioral response to a threat, in
which the somatic motor response stands out [29]. With
respect to the autonomic nervous system, both the sympa-
thetic and parasympathetic nervous systems participate in
inflammation. An early pathological motor response,
where the smooth muscular fiber is prominent, particu-
larly in the vascular system, is triggered [2,4,10]. The
whey-face is one of the most visible consequences of these
vasomotor responses.
The vasomotor response with vasoconstriction, which col-
laborates in the production of ischemia and vasodilation,
cause the redistribution of the local vascular and systemic
blood flow. The intensity and duration of this ischemia-
reperfusion phenomenon will modify the color of the tis-
sues and organs and will possibly determine their evolu-
tion during the subsequent inflammatory response. [2,4].
In this first phase of the inflammation, regardless whether
it is local or systemic, the tone or group of dominating
colors are those called cold colors, namely, blue and
green, which produce sedative effects. In particular, the
color blue, more or less dark, can be found after a
mechanical injury, both local (ecchymosis) and systemic
(cyanosis) (Figure 3).
The second-degree contusion initiates its evolution with
edema and ecchymosis (Figure 1). The initial dark blue
color of the ecchymotic lesion comes from the carboxyhe-
moglobin, which is the result of the bounding of carbon
monoxide to hemoglobin. Then, the release of hemo-
globin into the interstitial space is a phenomenon associ-
ated with hemolysis. Hemoglobin, released from red
blood cells, is the major source of heme for bile pigment
synthesis [31,32].
Heme is converted by heme-oxygenase (HO) forming
biliverdin, with blue-green color, carbon monoxide and
iron [32-34].
Three isoforms, HO-1, HO-2 and HO-3, are expressed in
most tissues. HO-1 is an inducible enzyme, also known as
heat shock protein 32, activated by oxidative stress and
cytokines [34]. HO-1 has antioxidant activity related to
the elimination of prooxidant heme, and to the antioxi-
dant properties of biliverdin [34,35]. Interplay between
HO-1 and nitric oxide synthase systems has recently been
addressed. These systems share many common features
and overlap in biological functions. Particularly, HO
activity is involved in the inhibitory effect of NO on neu-
trophil migration to the inflammatory site [36].
HO-2 and HO-3 display a constitutive expression. HO-2
may have an essential role in the execution of self-resolv-
ing inflammatory-reparative processes [37]. HO-3 in turn,
has a great structural homology with HO-2 and acts as a
heme-sensing/binding protein [38]. HO-2 may also regu-
late the expression of HO-1 by modulating the cellular
heme level [39]. Therefore, the pathophysiological mech-
anisms as a whole that are established in second-degree
contusions due to their antioxidant, anti-inflammatory
and reparative roles, would prevent the harmful evolution
of the lesion towards necrosis. In essence, the effects are
sedative where the expression of cold colors predomi-
nates.
Cyanosis, a word derived from the Greek term kyanos, is
the blue coloration of the skin, and the mucosas are fre-
quently associated with the traumatic pathology that have
a systemic effect with hypoxia and hypotension [40,41].
Central cyanosis, with blueness of skin, lips and mucous
membranes is always a manifestation of hypoxemia. As a
result of hypoxemia an excess amount of hemoglobin is
not saturated with oxygen; in currently accepted terminol-
ogy this unsaturated hemoglobin is said to be reduced
[42]. It is the quantity of reduced hemoglobin per deciliter
of capillary blood that accounts for the bluish color of cya-
nosis [43] (Figure 3).
- Warm Colors
During the immune phase of the inflammatory response,
the colors tend to be warmer. Thus, yellow coloration
arises.Page 5 of 15
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emergence of bilirubin, a bile pigment [31]. Bilirrubin is
produced via reduction of heme-derived biliverdin by
biliverdin-reductase [31,32]. However, biliverdin-reduct-
ase, an evolutionarily conserved protein found across the
spectrum of metazoans, also serves in a catabolic path-
way. Homologues of the reductase are found in unicellu-
lar organisms and plants [44,45]. Plants use biliverdin
produced by ferredoxin-dependent heme-oxygenase for
the synthesis of phytochromes, the sensory photorecep-
tors [44,45].
Biliverdin-reductase may function as a protein-kinase
[44]. Thus the functions are broadened since protein
phosphorylation by kinases and dephosphorylation by
phosphatases are essential components and mechanisms
of signal transduction in the cell [44]. So, biliverdin-
reductase plays an important role in mediating cytopro-
tective effects of HO-1 against hypoxia induced injury
[44,46]. Also the existence of a link between biliverdin-
reductase and the cytokine-activated stress signaling, sug-
gest its main role in mediating the inflammatory response
[44].
Bilirubin has a number of new and interesting biochemi-
cal and biological properties [47]. In addition to having a
protective role against oxidative stress [47,48] bilirubin
also has antiapoptotic [47,49] and antimutagenic proper-
ties [49]. Therefore, the increase in the production of
bilirubin in the bruised tissue may have beneficiary effects
as an inflammatory modulator.
In the immune phase of the inflammatory response, the
interstitium is infiltrated first by platelets and later by leu-
kocytes [5,50-52]. Acute inflammation following injury is
the site for abundant production of ROS by phagocytic
NADPH oxidase. In turn, this active oxidase is composed
of a membrane-bound cytochrome [5]. In these injured
tissues showing oxidative stress, and sometimes, symbio-
sis of the inflammatory cells and bacteria, the degree of
enzymatic stress could increase [11].
Pyogenic bacteria, such as Staphylococcus aureus, makes the
inflammatory process yellow [53]. The genus Staphylococ-
cus describes a grapelike cluster of bacteria found in pus
from surgical abscesses, since staphylo means grape in
Greek. Aureus is the species name, and means golden in
Latin, that is its characteristic surface pigmentation in
comparison with less virulent Staphylococci. Studies of the
Staphylococcus aureus pigment have unraveled a biosyn-
thetic pathway that produces carotenoids, which are also
a type of plant coloring with antioxidants [53]. Although
this is not a tetrapyrrholic derived pigment, its situation in
the scale of warm colors is interesting.
The formation of yellow, milky yellow, greenish yellow or
white-yellow pus characterizes suppuration or purulent
inflammation [54,55] (Figure 3). In addition to the
enzymes released by granulocytes during the process of
phagocytosis and bacterial killing, the bacteria themselves
produce a number of exoenzymes that cause tissue
destruction as well as localization of infection [56,57]. In
particular, almost all Staphylococcus aureus strains have the
ability to secrete an array of enzymes including nucleases,
proteases, lipases, hyaluronidase, and collagenase [57].
Matrix metalloproteinases would also collaborate in the
development of enzymatic stress in the acute inflamma-
tory tissue injury [58,59]. Pus mainly contains necrotic tis-
sue debris and dead neutrophils and, when the collection
of pus is localized, an abscess is established [56,57].
Compensation of the acute phase response includes the
production of positive acute phase proteins, like α2-mac-
roglobulin, that binds proteolytic enzymes, and α1-antit-
rypsin and α1-antichymotrypsin, which are inhibitors of
leukocyte and lysosomal proteolytic enzymes [60]. Like-
wise, the natural inhibitors of matrix metalloproteinases
(TIMPs) could promote antienzymatic stress [58].
Also, unconjugated bilirubin is a potent inhibitor of the
digestive proteases trypsin and chymotrypsin [61]. In the
gut, bilirubin glucuronides are deconjugated by beta-glu-
curonidase, which exists in the gut mucosa, and could also
be also found in some strains of bacteria such as
Escherichia coli and Streptococcus pyogenes. Therefore, it has
been accepted that a dramatic decrease of beta-glucuroni-
dase-positive bacteria, which in turn results in impaired
inactivation of digestive enzyme from the pancreas in the
large intestine would favor the development of inflamma-
tion in this location [61,62].
The ability of Staphylococcus aureus to cause infection is
absolutely dependent on the acquisition of iron from the
host. Particularly, the most abundant iron source is in the
form of the porphyrin heme [63,64]. That is why it has
been suggested that the ultimate fate of exogenously
acquired heme in Staphylococcus aureus depends on the
intracellular and extracellular availability of both iron and
heme. It also plays a significant role in the infectious proc-
ess [64].
The yellowish coloring of the skin and mucosas is called
icterus (or jaundice). This means yellowness, ikteros in
Greek. Postoperative jaundice is associated with elevated
serum bilirubin, mainly conjugated, above 3 mg per dl.
Although hyperbilirubinemia seems to be multifactorial,
perioperative hypotension and/or hypoxia are important
pathogenic factors in the development of postoperative
jaundice and multiple organ failure [65]. In patients with
sepsis and multiple organ failure, a serum total bilirubinPage 6 of 15
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mortality [66].
Jaundice is an important and transient clinical sign seen in
most healthy newborns. They have hyperbilirubinemia
but finding the cause is not often possible [67]. Neverthe-
less, increased concentrations of IL-1 beta in the colos-
trum from breast-feeding mothers whose infants had
neonatal jaundice has been demonstrated. Therefore,
cytokines could be involved in the pathophysiological
events that can lead to neonatal jaundice [68].
However, the relation of the biliary pigments to infection
is ambivalent since increasing serum levels of biliverdin
and bilirubin were shown to be beneficial in the setting of
inflammation [69]. Thus, in a mouse model of endotox-
emia, a single-dose administration of bilirubin, in addi-
tion to its antioxidant effects, also exerts potent anti-
inflammatory activity [69].
The maximum intensity of the immune response may be
reached when an associated systemic infection is pro-
duced. Failure of the intestinal barrier resulting in bacte-
rial translocation worsens the systemic inflammatory
response syndrome in the polytraumatized patient, and it
is an important etiological factor of sepsis and multiple
organ failure [70-72].
Hypovolemic shock, severe hemorrhage or major surgery
lead to priming the host and the exposure to a posterior
bacterial stimulus can produce an excessive response to an
otherwise low-grade inflammatory trigger [73,74]. Most
likely a current definition of sepsis is too broad and
encompasses heterogeneous groups of patients suffering
similar but different immune syndromes that are histori-
cally grouped under the general diagnosis of sepsis [75].
Cholestatic jaundice also occurs in the setting of sepsis
[76]. Liver abnormalities in sepsis include cholestasis and
hyperbilirubinemia. Gram-negative infections used to be
the cause of cholestasis associated with sepsis [76]. Hyper-
bilirubinemia develops in sepsis particularly in the setting
of bacteriemia. Hyperbilirubinemia precedes positive
blood cultures in one third of cases [77]. Bile pigments
have apoptotic protective and proliferative effects in vitro,
therefore caution should be exercised when generalising
these functions or properties [49]. In addition to the pos-
sibility that bile pigments, like other porphyrins, interact
with and neutralise mutagens, they may also have unique
mechanistic effects that regulate cell apoptosis and car-
cinogenesis. The porphyrins, including biliverdin,
bilirubin, protoporphyrin, hemin and clorophyllin are
effective anti-mutagens. Particularly, bilirubin induces
apoptosis in adenocarcinoma cell lines by disrupting the
mitochondrial membrane potential and arresting the cell
cycle through a prooxidant mechanism [49].
- Hot colors
Evidence shows that the intensity and duration of the
nervous and immune phases of the inflammatory
response condition the evolution of the last or endocrine
phase. Thus, oxidative and enzymatic stress, both which
dominate the initial phases of inflammation, according to
their intensity and duration, would regulate the type of
response that is produced during the final or endocrine
phase. [2,4].
Platelets [78], mast cells [79], neutrophils [80,81], macro-
phages [82-84] and T cells [79,84] are characterized by
expert functions in assisting and modulating the inflam-
matory response. Even today the potential role of leuko-
cyte-derived neuropeptides and hormones in
inflammation as a localized hypothalamic-pituitary-like
axis has been proposed [85]. As the inflammatory
response progresses, certain stop signals at appropriate
checkpoints prevent further edema production and leuko-
cyte traffic into tissues [83,86]. The pro-inflammatory
mechanisms are counterbalanced by endogenous anti-
inflammatory signals, that serve to temper the severity
and limit the duration of the early phases, which leads to
their resolution [83,86,87]. It has been proposed that reg-
ulatory T cells (Treg cells) have evolved to provide a com-
plementary immunological arm to a physiological tissue-
protecting mechanism driven by low oxygen tension (i.e.
hypoxia) in inflamed tissues. The hypoxia-adenosinergic
pathways migth govern the production of immunosup-
pressive molecules that have already been implicated in
the activities of Treg cells. In this way, by virtue of acting
in hypoxic and extracellular adenosine-rich tissue, T reg
cells could exert their suppressive function with local
downregulation of immune response, inducing "immun-
odormancy", and protection of tissues from continuing
collateral tissue damage thus improving healing [88] (Fig-
ure 3).
However, the interstitium is considered as the battle field
where inflammation develops [2,4,5] and its equivalent
in tissues and organs is the stroma. At the same time, the
most abundant cell type of tissue stroma is the fibroblast,
an active heterogeneous population of cells [89]. Fibrob-
lasts can modify the quality, quantity and length of the
inflammatory infiltration during the induction of the
inflammatory response [90]. Fibroblasts can also contrib-
ute to the resolution of inflammation by withdrawing sur-
vival signals and normalizing chemokine gradients,
thereby allowing infiltrating leukocytes to undergo apop-
tosis or leave the tissues through the draining lymphatics
[91]. Lastly, fibroblasts may also provide important posi-
tional cues for wound healing and tissue regeneration. InPage 7 of 15
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they may facilitate angiogenesis by production and release
of growth factors [89].
The color red is the first of the solar spectrum and is
applied to the color of arterial blood, namely, when the
blood contains oxyhemoglobin (HbO2). The reflectance
spectra for human skin has a characteristic signature, due
to the absorption spectrum of oxygenated hemoglobin in
the blood, and provides leads about the evolution of pri-
mate color vision [92,93].
Oxyhemoglobin reaches the cells through the capillaries
as a result of angiogenesis. This process, with neoforma-
tion of capillaries, would characterize the last or endo-
crine phase of the inflammatory response [4,11]. The
relatively low solubility of oxygen combined with its rapid
consumption, puts cells that are more than a hundred
microns or so away from the atmosphere in the precarious
position of relying on the microcirculation to maintain
oxygen supply where an interruption in blood flow of
only a few minutes can be disastrous [93]. Metabolically
active tissues extract approximately 75% of all the oxygen
from the blood as it passes from arterial input to venous
output, resulting in significant intracellular gradients and
intratissue heterogeneity of oxygen [93]. The oxygen dis-
sociation curve of hemoglobin, a respiratory linked pro-
tein, has profound clinical importance applicable to
numerous situations of health and disease, for example,
in the neonatal period, aging, anesthesia, surgery, hemor-
rhage and septic shock [94,95].
Flesh color is the common color of the tissues due to its
content of oxyhemoglobin. The ability to use oxygen,
when it is disassociated from hemoglobin in the oxidative
metabolism, is recovered when patients recover their cap-
illary function and therefore, nutrition is mediated by
them in the so-called endocrine or late phase. This type of
metabolism is characterized by a large production of ATP
(coupled reaction), which is used to drive multiple spe-
cialized cellular processes (energetic stress) with limited
heat generation and it would determine the onset of heal-
ing [2,4,11].
Therefore, the blood cells that occupy the interstitial space
in this latter phase of the inflammatory response are red
blood cells [2,4]. To carry out this interstitial occupation,
the red blood cells are transported by the newly formed
blood capillaries [96] and, therefore, angiogenesis is con-
sidered to play the main role in this inflammatory period
[2,4,10,11] (Figure 3).
The best way to finish the post-traumatic inflammatory
response, both local or systemic, is with regeneration
since the tissue and/or organ physiology returns to their
normal state [86]. Regeneration is a process known well
by the body since it is produced right afterwards and in
particular by the epithelial tissues. Regeneration could be
considered a good method of fighting against the ener-
getic stress that the oxidative metabolism imposes on the
epithelial cells [4,11].
Recently, lipoxins, resolvins, protectins [97-99] and
vasoinhibins [100] have emerged as signaling molecules
that regulate many cell functions and ample evidence
emphasizes their role in the resolution of the inflamma-
tory response [86]. Resolution is an active and tightly reg-
ulated process controlled by anti-inflammatory and pro-
resolving mediators and cellular moities [86,98]. Emerg-
ing evidence now suggests that this process of resolution
initiates in the first few hours after an inflammatory
response begins [83]. Therefore, this process could be sim-
ilar to other fermentation processes as in bread-, wine-
and cheese-making. In the first case the flour is mixed with
water, salt (edema, oxidative stress) and it ferments. Then
it is baked in the oven to obtain bread.
Like in a cooking recipe, it is possible that the final prod-
uct of the post-traumatic inflammatory response depends
on how many components are used, like water, electro-
lytes, enzymes, pro-inflammatory cytokines, growth fac-
tors and hormones, as well as the time employed in each
phase of the elaboration.
The ideal result is the resolution of tissue and organ recov-
ery to a normal state. Mammals have retained much of the
molecular machinery used by organisms such as salaman-
ders, but their regenerative potential is only limited. In
part, this seems to result from the rapid interposition of
fibrotic tissue which prevents subsequent tissue regenera-
tion [101]. However, there are other alternative solutions.
By default, an impairment of wound healing and chronic
hypoinflammation is produced. At the same time, by
excess, the healing is produced by repair with fibrous scar
or by fibroproliferative scars [51,84,101,102]. Chronic
non-healing wounds generally are due to ischemia and
multiple factors that contribute to their resistance to treat-
ment [102]. Under conditions of chronic inflammatory
hypoxia, chronic ischemic tissue requires adequate
wound tissue oxygenation, among other factors, to
improve the healing proccess [5]. The fibrous scar is sec-
ondary to excessive traumatic tissue necrosis with forma-
tion of rosy granulation tissue [51]. Lastly, prolonged
inflammation in wounds contributes to the development
of fibroproliferative scars, in other words, keloids and
hypertrophic scars, both erithematous [103]. Free heme
plays a major role in the expression of chronic inflamma-
tion. It activates neutrophil functions and delays neu-
trophil apoptosis. For these reasons heme is considered a
pro-inflammatory molecule [104].Page 8 of 15
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mediated by myofibroblasts or by cells that gain a myofi-
broblasts-like phenotype; their activities include the
abundant synthesis of fibrillar collagens [105]. In this
way, the remodeling of tissues by fibrosis could be a use-
ful solution to combat the energetic stress associated with
the oxidative metabolism since the cellular content
diminishes and the metabolic demand increases the extra-
cellular component of reduced vitality.
During prolonged critical illness, lean tissue is wasted
despite feeding; a problem that often persists even after
the underlying disease has been resolved. In this chronic
phase of the critical illness, the wasting syndrome is asso-
ciated with a neuroendocrine dysfunction characterized
by a hypothalamic rather than pituitary dysfunction
[1,2,106]. During the evolution of the nervous and
immune phases of the systemic inflammatory response,
the body loses its more specialized functions and struc-
tures. In this progressive deconstruction, there is a deple-
tion of the hydrocarbonate, lipid and protein stores, as
well as multiple or successive dysfunction and posterior
failure or necrosis of the specialized epithelium, i.e., the
pulmonary, gastrointestinal, renal and hepatic ones
[2,4,107].
However, consumption of the substrate deposits and the
dysfunction or failure of the specialized epithelia of the
body could also represent an accelerated process of dedif-
ferentiation [2,4]. The hypothetical ability of the body to
involute or dedifferentiate could represent a return to
early stages of development. Therefore, dedifferentiation,
although it means the risk of neoplastic transformation,
can also be a form of effective defense mechanism against
injury since it could make retracing a well-known route
possible, that is, the prenatal specialization phase during
the endocrine phase of the systemic inflammatory
response. This last phase of the inflammatory response
has the disadvantage that it develops in an extrauterine
environment without the functional support of the
mother with her placenta [2,4]. The elevated incidence of
post-traumatic stress syndromes would thus be explained
as a consequence of a frustrated recovery of homeostasis.
Tetrapyrrole molecules in physiology and pathology
- Light, pigments and life
The importance of color in the surgical pathology could
be attributed to the benefits for the diagnosis and treat-
ment of diseases. However, this coloring can also have
added-value related to its possible pathophysiological
importance. This possibility has not yet been fully discov-
ered, which would allow us to better understand its mean-
ing in Nature.
Color depends on light, which is a kind of energy that the
sun emits in the form of radiation [92,93]. The use of the
sun's light energy by photosynthetic organisms provides
the foundation for virtually all life on Earth [108].
Photosynthesis efficiently converts light energy to electro-
chemical energy for oxidation-reduction (redox) reac-
tions. The direct products of oxygenic photosynthesis are
carbohydrates and oxygen [108].
Photosynthetic pigments are categorized in three chemi-
cal groups: chlorophylls, carotenoids and phycobilins.
Chlorophylls are essential molecules of green algae and
land plants. They are responsible for harvesting solar
energy in photosynthetic systems but also influence proc-
esses, such as photosynthetic gene expression, growth
rates and cell-death [109,110] (Figure 4).
Protagonism of the Tetrapyrrole molecules in vegetal and anim l kingdomsFigure 4
Protagonism of the Tetrapyrrole molecules in vege-
tal and animal kingdoms. Tetrapyrrole products allow 
plants to use CO2and mammals to use O2. These molecules 
in their color version take advantage of the solar spectrum, 
produced by the dispersion of sunlight and so they would 
play the main role in the origin of plant and animal life, and 
therefore, in inflammation.Page 9 of 15
(page number not for citation purposes)
Journal of Translational Medicine 2009, 7:19 http://www.translational-medicine.com/content/7/1/19Thus, the chlorophyll biosynthetic and degradation reac-
tions belong to the most important biochemical pathways
known [109]. However, in addition to chlorophylls, other
tetrapyrrole end products are synthesized through the
same pathway including heme, hemoglobin, myoglobin,
cytochromes, nitric oxide synthase, peroxidase and cata-
lases [33,109].
Tetrapyrrole molecules, such as heme, are employed in a
number of biochemical processes in algae, plants
[108,109], bacteria [108,111] and mammals [112] and
therefore allow for establishing links between their
metabolism and functions [113].
This large functional capacity of the tetrapyrrole mole-
cules, explains why plants, through photosynthesis and
mammals through respiration, are complemented in the
creation of increasingly more complex forms of life
[108,109,114,115]. Therefore, photosynthetic pigments
and oxygen on extrasolar planets are considered strong
biomarkers for detecting life [116].
- Pigments, oxygen and inflammation
Due to the major importance of the tetrapyrrole mole-
cules in the evolution of life on Earth [108] we could also
presuppose that these molecules play a leading role, not
only in physiological situations but also in inflammation,
since this is a vital process for the body.
Inflammation has been linked to the nutritional altera-
tion in affected tissues from ancient times. In 1877 San-
tiago Ramón y Cajal, to obtain his doctor's degree,
presented a manuscript titled Patogeny of the Inflammation,
(the original version can be read at the Complutense Uni-
versity Medical School Library, although it has also been
published in a facsimile edition) [117]. The future Span-
ish Nobel Prize winner cited the existence of disorders or
perturbations of the nutritional activity in the organic ter-
ritory subject to irritation, seconding Virchow. These
authors considered that the essential phenomenon of the
inflammatory process was irritation of the cell, which
would be expressed by feeding the cell itself most actively,
while exaggerating its function and by cell genesis [117].
Thus, we have proposed that the sequence in the expres-
sion of progressively more elaborated and complex nutri-
tional systems could hypothetically be considered the
essence of the inflammation, regardless of what its etiol-
ogy or localization may be [2,4,5,10]. The successive
pathophysiological mechanisms that develop in the inter-
stitium of tissues when they undergo acute post-traumatic
inflammation are considered increasingly complex
trophic functional systems for using oxygen. The expres-
sion of the nervous (excessive oxidative and nitrosative
stress), immune (enzymatic stress) and endocrine (ener-
getic stress) functional systems during the inflammatory
response makes it possible to differentiate three successive
phases, which progress from ischemia, through a metabo-
lism that is characterized by defective oxygen use (reper-
fusion, oxidative burst and heat hyperproduction), up to
an oxidative metabolism (oxidative phosphorylation)
with the correct use of oxygen that produces usable
energy. Hence, the incidence of harmful influences during
their evolution could involve regressing to the most prim-
itive trophic stages, in which nutrition by diffusion (nerv-
ous phase) takes place. This is simpler, but also less costly
and facilitates temporary survival until a more favorable
environment makes it possible to initiate more complex
nutritional methods (immune and endocrine phases)
[2,4,10,11]. The ability of cells to adapt to hypoxia relies
on a set of hypoxia-inducible transcription factors (HIFs)
that induce a transcriptional programme of genes that reg-
ulate cell survival and apoptosis, vascular tone and angio-
genesis [118]. A metabolic adaptation to hypoxia involves
that cells switch from aerobic to anaerobic metabolism
("Pasteur effect"). By this mechanism the cell can con-
tinue to generate ATP and can try to meet the metabolic
demands [118]. The oxygen sensors in conjunction with
HIFs regulate various aspects of this metabolic adaptation
[118]. Endothelial cells, through their capacity of anaero-
bic metabolism, could tolerate the ischemia phase and,
indeed play an antioxidant role [119]
Thus, it is also tempting to speculate on whether the body
reproduces the successive stages from which life passes
from its origin without oxygen [120] until it develops an
effective, although costly, system for the use of oxygen
every time we suffer acute inflammation [4,10,11].
Oxygen availability is coupled with an increase in network
complexity beyond what is reachable by any anoxic net-
work. It also highlights enzymes and metabolic pathways
that might have been important in the adaptation to the
oxic atmosphere produced only by a single biological
reaction: oxygenic photosynthesis. Therefore, a correla-
tion between the increased organism complexity and the
development of the use of the atmospheric oxygen could
be established [120,121]. This correlation also seems to
exist in the evolutive phases of the inflammatory response
since progressive cellular and tissue complexity occur par-
allel to a gradual oxygenation process from ischemia, to
progressive reoxygenation until the correct revasculariza-
tion by angiogenesis in the injured tissues (Figure 4).
Tetrapyrrole end products also accompany the evolution
of the inflammatory response from the beginning with
ischemia to the end with oxidative phosphorylation.
Thus, traumatic injury with cell damage and hemolysis
can lead to high tissue concentrations of free heme, caus-
ing oxidative stress [122,123] and chemotactic call for leu-Page 10 of 15
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antioxidative effect [33]. Biliverdin and bilirubin down-
regulate pro-inflammation [36,47-49,69]. Hemoglobin
transports oxygen in the erythrocytes and cytochrome-C-
oxidase is the terminal enzyme in the respiratory chain
which allows for the synthesis of ATP, where the energy of
food consumption and respiration is stored [124]. The
five different cytochromes in the respiratory chain consti-
tuting a family of colored proteins that are related by the
presence of a bound heme molecule whose iron atom
changes from the ferric to ferrous state whenever it accepts
an electron. Hemes in different cytochromes have a
slightly different structure and each cytochrome has a dif-
ferent affinity for an electron [5,33]. Therefore, it could be
considered that the continuous interaction of tetrapyrrole
molecules and oxygen, dominate the inflammatory
response and perhaps reflect the thorough control that
animal life should carry out with regards to this toxic cell
potential, which is oxygen. Perhaps this is why once oxy-
gen reaches the capillaries of the new formed tissues,
whether by regeneration or by fibroplasia, the cells have
to pay a very high price to obtain energy, since they overly
increase their turnover (regeneration) or reduce energy to
the maximum, until acquiring a tissue with the least
amount of cells, and therefore, one with very little vitality
(fibrosis).
Potential clinical applications
Sir Alan Battersby recounts that chemists and biochemists
sometimes argue over coffee, each pressing the case for the
greater importance of one group of natural products rela-
tive to another. Of course, this is largely for fun since liv-
ing things and their chemistry are so interlocked and
interdependent that (were it possible) elimination of any
one family of natural products would probably bring eve-
rything crashing down [125]. This outcome is certainly so
for tetrapyrroles since they are responsible "inter alia", for
oxygen transport (haem), electron transport (cytochrome
c) and most fundamentally, photosynthesis (chlorophyll)
(Figure 4). Indeed, without the chlorophylls and bilins
(e.g. Phycocyanin which acts as a light haverster in algae)
life as we know it should not exist on this planet [125].
That is why it could be considered that tetrapyrrole mole-
cules would be closely related to the different types of
metabolisms exhibited by injured tissue during the
inflammatory response. In particular, different intermedi-
ate tetrapyrroles would correspond to each post-traumatic
metabolic state. Thus, through the regulation of tetrapyr-
role biosynthesis genes, intermediates would be produced
[125,126] in the successive phases of post-traumatic
inflammation. Therefore, the assessment of color changes
in tissues, attributed to the pigment characteristics of sev-
eral tetrapyrroles, would possess a value for diagnosis and
prognosis, and they would correlate with the metabolic
level of the inflamed tissue. In essence, this correlation is
also produced in the plant kingdom. Thus, the color
changes that occur during foliar senescence have also
demonstrated that they are directly related to the regula-
tion of nutrient mobilization and re-absorption from leaf
cells. Chlorophyll is degraded through a metabolic path-
way that becomes specifically activated in leaf senescence.
Furthermore, bright autumn colors observed in the foliage
of some woody species have been hypothesized to act as a
defense signal to potential insect herbivores [127].
A multicolor digital image analysis system for simultane-
ous identification of the tetrapyrrole pigments in the
inflamed tissue and assessment of their metabolic activity
would constitute a diagnostic method of great interest
(see appendix). A rapid and simple multicolor image
analysis has been developed recently for simultaneous
identification of bacteria species and assessment of meta-
bolic activity [128].
Undoubtedly, other alternatives would include experi-
mental and clinical applications of metabolomics. Metab-
olomics, an omic science in biological systems, is the study
of global metabolite profiles in a system (cell, tissue or
organism) under a given set of conditions [129,130].
Metabolomics, when used as a translational research tool,
can provide a link between the laboratory and clinic, par-
ticularly because metabolic and molecular imaging tech-
nologies such as position emission tomography and
nuclear magnetic resonance spectroscopic imaging enable
the discrimination of metabolic markers non-invasively
in vivo [130]. Gas chromatography and liquid chromatog-
raphy-mass spectrometry are also important analytical
techniques for metabolomic analysis [129,131,132].
Therefore, the fusion of molecular/metabolic, and ana-
tomical/morphological information could improve the
diagnostic accuracy in the identification and characteriza-
tion of the successive phases of the post-traumatic inflam-
matory response in relation to the metabolism of
tetrapyrroles.
Conclusion
We could conclude that the close relationship that the
tetrapyrrole end products establish with oxygen to acquire
forms of life on Earth are based on oxidative metabolism.
This would also explain the tetrapyrrole end products
location in the successive phases of the inflammatory
response and so, phylogeny could be recapitulated
[5,133] (Figure 4). Furthermore, the profusion with which
nature uses tetrapyrrole derivates, including pigments in
virtually all living organisms on Earth [116,134], could
make possible their incorporation into our diagnostic and
therapeutic arsenal. Then, the final aim of their use in the
clinical area would be to achieve a similar efficiency in
maintaining our life, when threatening factors arise.Page 11 of 15
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Appendix: Tetrapyrroles and other pigment 
compounds involved in color production and in 
the inflammatory response evolution
• Haem. An alternative spelling for heme
• Heme. Heme a – C49H56O6N4Fe – Cytochrome a refers
to the heme A in specific combination with membrane
protein forming a portion of Cytochrome C oxidase.
Heme b – C34H32O4N4Fe
Heme c – C34H36O4N4S2Fe
• Hemoglobin (Hb). A metalloprotein (globin)
Hemoglobin A (α2β2) is the most common in human
adults.
• Carboxyhemoglobin – Complex of carbon monoxide
and hemoglobin (COHb)
• Nitrix oxide synthase (NOS) – A eukaryotic enzyme cal-
modulin-containing cytochrome P450-like hemoprotein.
• Peroxidase – Can contain a heme cofactor in their active
site. It is an electron donor. The optimal sustrate is hidro-
gen peroxide (H2O2).
• Catalase – Contains four porphyrin heme groups that
allow the enzyme to react with the H2O2 to form water
and oxygen.
• Porphyrin – A natural pigment containing a fundamen-
tal skeleton of four pyrrole nuclei united by methine
groups.
• Photosynthetic pigments:




- Carotenoids – Organic pigments that naturally occur
in
chromoplasts of plants and some other
photosynthetic organisms like algae, fungus
and some bacteria. There are two classes:
. xanthophylls
and
. carotenes – A yellow-orange-red pigments
(tetraterpenoids)
- Phycobilins – Light capturing molecules (chromo-
phores)
- blue (phycocyanobilin)
- orange (phycourobilin) and
- red (phycoerythrobilin)
All of them in cyanobacteriae.
• Biliverdin – A green pigment formed as a by-product of
heme breakdown (C33H34N4O6).
• Bilirubin – A yellow breakdown product of normal
heme catabolism (C33H34N4O6)
• Bilirubin glucuronides – Bilirubin glucoronidation reac-





- Urobilinogen is a colorless product of bilirubin reduc-
tion (C33H44N4O6)
- Urobilin is a yellow linear tetrapyrrole produced when
urobilinogen is oxidized by intestinal bacteria. This pro-
duces a brown pigment excreted in urine (C33H42N4O6).
. Cytochromes
- Cytochrome C oxidase. The last enzyme in the respira-
tory electron transport chain. The complex contains two
hemes, a cytochrome a and cytochrome a3 and two copper
centers.Page 12 of 15
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hemoproteins found in all domains of life. Acts as termi-
nal oxidase in multicomponent electron-transfer chains,
called P450-containing monooxygenase systems.
. Myoglobin. A globular protein containing a heme pros-
thetic group. It is the primary oxygen-carrying pigment of
muscle tissues and responsible for making these tissues
red.
• Oxyhemoglobin. Heme group contains one iron atom
that can bind one oxygen molecule through ion-induced
dipole forces (HbO2). It is the oxygen-loaded form of
hemoglobin.
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